OS THERAPIES INCORPORATED

NYSE: OSTX (OS Therapies Incorporated)

Last update: 9 hours ago

1.26

-0.01 (-0.79%)

Previous Close 1.27
Open 1.27
Volume 249,326
Avg. Volume (3M) 584,275
Market Cap 58,974,592
Price / Book 13.65
52 Weeks Range
1.15 (-8%) — 2.25 (78%)
Earnings Date 16 Nov 2026
Diluted EPS (TTM) -0.990
Current Ratio (MRQ) 1.16
Operating Cash Flow (TTM) -10.08 M
Levered Free Cash Flow (TTM) -12.28 M
Return on Assets (TTM) -263.81%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock OS Therapies Incorporated - -

AIStockmoo Score

-1.1
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages -2.5
Technical Oscillators -2.5
Relative Valuation NA
Financial Health NA
AI Insight NA
Weighted Average -1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
OSTX 59 M - - 13.65
CYBN 359 M - - 2.70
LCTX 252 M - - 3.97
PLX 205 M - 11.07 3.16
ARMP 114 M - - -
NRXS 96 M - - 13.64

Select this tab to load the latest available analysis.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.

Sector Healthcare
Industry Biotechnology
% Held by Insiders 33.38%
% Held by Institutions 1.38%

Ownership

Name Date Shares Held
Howard Financial Services, Ltd. 30 Sep 2026 248,001
Beacon Pointe Advisors, Llc 30 Jun 2026 62,507
Ingalls & Snyder Llc 30 Jun 2026 36,676

No data within this time range.

No data within this time range.

AI Technical Analysis

Open the Technical tab to generate the latest analysis.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria